===== phenotype 22=================================================================
proportion of pts: 0.153510511702
lambda: 22146.0744044
----------------------------------------
Diabetes	0.123
Ischemic heart disease	0.122
Disorders of lipoid metabolism	0.116
Hypertensive disease	0.099
Range name na	0.066
Symptoms involving respiratory system and other chest symptoms	0.049
Anemias	0.049
Nephritis, nephrotic syndrome, and nephrosis	0.049
Other forms of heart disease	0.042
General symptoms	0.040
Rheumatism, excluding the back	0.039
Other diseases of respiratory system	0.033
Mycoses	0.029
Symptoms involving skin and other integumentary tissue	0.027
Other diseases of urinary system	0.027
Acute respiratory infections	0.024
Diseases of arteries, arterioles, and capillaries	0.023
Dorsopathies	0.022
Diseases of the ear and mastoid process	0.022
----------------------------------------
Hypoglycemic Agents	0.049
Vitamin B Complex	0.047
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.046
Platelet Aggregation Inhibitors	0.045
Cyclooxygenase Inhibitors	0.045
Anticholesteremic Agents	0.045
Fibrinolytic Agents	0.044
Antihypertensive Agents	0.043
Anti-Inflammatory Agents, Non-Steroidal	0.042
Adrenergic beta-Antagonists	0.040
Adrenergic alpha-1 Receptor Antagonists	0.040
Antipyretics	0.040
Angiotensin-Converting Enzyme Inhibitors	0.038
Hypolipidemic Agents	0.038
Antioxidants	0.035
Vasodilator Agents	0.033
Anti-Arrhythmia Agents	0.032
Cardiotonic Agents	0.032
Hematinics	0.031
Vitamins	0.031
Sympatholytics	0.029
Diuretics	0.029
Sodium Potassium Chloride Symporter Inhibitors	0.029
Immunosuppressive Agents	0.026
Adrenergic beta-1 Receptor Antagonists	0.025
Enzyme Inhibitors	0.024
Anti-Inflammatory Agents	0.022
Dermatologic Agents	0.020
===== phenotype 20=================================================================
proportion of pts: 0.159063863546
lambda: 21993.5503351
----------------------------------------
Disorders of lipoid metabolism	0.126
Hypertensive disease	0.121
Arthropathies and related disorders	0.103
Ischemic heart disease	0.093
Range name na	0.069
Nonspecific findings on examination of blood	0.062
Other forms of heart disease	0.060
Rheumatism, excluding the back	0.053
Disorders of the eye and adnexa	0.044
Malignant neoplasm of male and female genital organs	0.043
Dorsopathies	0.039
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.034
Diseases of male genital organs	0.032
Nutritional deficiencies	0.032
Anemias	0.023
Symptoms involving cardiovascular system	0.022
General symptoms	0.022
Symptoms involving urinary system	0.022
----------------------------------------
Antihypertensive Agents	0.060
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.057
Anti-Inflammatory Agents, Non-Steroidal	0.054
Cyclooxygenase Inhibitors	0.054
Anticholesteremic Agents	0.054
Antipyretics	0.053
Platelet Aggregation Inhibitors	0.052
Fibrinolytic Agents	0.052
Vasodilator Agents	0.046
Angiotensin-Converting Enzyme Inhibitors	0.046
Anti-Arrhythmia Agents	0.044
Sympatholytics	0.040
Hypolipidemic Agents	0.039
Vitamins	0.039
Adrenergic beta-1 Receptor Antagonists	0.037
Cardiotonic Agents	0.035
Antioxidants	0.033
Calcium Channel Blockers	0.031
Vitamin B Complex	0.028
Bone Density Conservation Agents	0.027
Sodium Chloride Symporter Inhibitors	0.025
Adrenergic beta-Antagonists	0.024
Diuretics	0.024
Adrenergic alpha-1 Receptor Antagonists	0.023
Analgesics, Non-Narcotic	0.022
===== phenotype 6=================================================================
proportion of pts: 0.141213804046
lambda: 21366.8762584
----------------------------------------
Hypertensive disease	0.089
Range name na	0.088
Rheumatism, excluding the back	0.088
Diabetes	0.082
Arthropathies and related disorders	0.080
Disorders of lipoid metabolism	0.063
Infections of skin and subcutaneous tissue	0.062
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.060
Symptoms involving skin and other integumentary tissue	0.058
Other forms of heart disease	0.058
General symptoms	0.054
Nutritional deficiencies	0.043
Other diseases of skin and subcutaneous tissue	0.038
Disorders of the eye and adnexa	0.031
Mycoses	0.030
Cerebrovascular disease	0.030
Open wound	0.026
Overweight, obesity and other hyperalimentation	0.020
----------------------------------------
Sodium Potassium Chloride Symporter Inhibitors	0.037
Antihypertensive Agents	0.035
Anticoagulants	0.034
Diuretics	0.033
Anti-Bacterial Agents	0.032
Rodenticides	0.031
Antimalarials	0.031
Tubulin Modulators	0.031
Anti-Arrhythmia Agents	0.030
Antipyretics	0.030
Vitamin B Complex	0.030
Anti-Infective Agents, Urinary	0.030
Analgesics, Non-Narcotic	0.030
Hypoglycemic Agents	0.029
Angiotensin-Converting Enzyme Inhibitors	0.029
Antineoplastic Agents, Phytogenic	0.028
Anti-Infective Agents, Local	0.028
Vitamins	0.027
Bone Density Conservation Agents	0.026
Cardiotonic Agents	0.026
Anti-Infective Agents	0.026
Anti-Allergic Agents	0.025
Sympatholytics	0.025
Antimetabolites	0.025
Anti-Inflammatory Agents, Non-Steroidal	0.024
Enzyme Inhibitors	0.024
Immunosuppressive Agents	0.023
Antidepressive Agents, Tricyclic	0.023
Fibrinolytic Agents	0.023
Cyclooxygenase Inhibitors	0.023
Histamine H1 Antagonists, Non-Sedating	0.023
Platelet Aggregation Inhibitors	0.023
Vasodilator Agents	0.022
Adrenergic beta-1 Receptor Antagonists	0.021
Mutagens	0.021
Anti-Inflammatory Agents	0.021
Antioxidants	0.021
===== phenotype 48=================================================================
proportion of pts: 0.151130503768
lambda: 20581.564767
----------------------------------------
Disorders of the eye and adnexa	0.119
Other diseases of the upper respiratory tract	0.096
Hypertensive disease	0.093
Symptoms involving head and neck	0.083
Disorders of lipoid metabolism	0.080
Diseases of the ear and mastoid process	0.071
Organic sleep disorders	0.069
Range name na	0.058
General symptoms	0.057
Symptoms involving skin and other integumentary tissue	0.053
Nutritional deficiencies	0.040
Neurotic, personality, nonpsychotic disorders	0.037
Disorders of thyroid gland	0.035
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.032
Na	0.030
Diseases of esophagus, stomach, and duodenum	0.024
Other inflammatory conditions of skin and subcutaneous tissue	0.021
----------------------------------------
Antihypertensive Agents	0.050
Anti-Allergic Agents	0.046
Anti-Inflammatory Agents	0.040
Anti-Inflammatory Agents, Non-Steroidal	0.039
Antipyretics	0.039
Cyclooxygenase Inhibitors	0.038
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.038
Anticholesteremic Agents	0.035
Bronchodilator Agents	0.035
Platelet Aggregation Inhibitors	0.035
Fibrinolytic Agents	0.034
Histamine H1 Antagonists, Non-Sedating	0.032
Dermatologic Agents	0.031
Angiotensin-Converting Enzyme Inhibitors	0.031
Hypnotics and Sedatives	0.030
Anti-Arrhythmia Agents	0.029
Diuretics	0.029
Serotonin Uptake Inhibitors	0.028
Antidepressive Agents, Second-Generation	0.028
Hypolipidemic Agents	0.028
Histamine H1 Antagonists	0.027
Vasodilator Agents	0.026
Sympatholytics	0.026
Cardiotonic Agents	0.025
Sodium Chloride Symporter Inhibitors	0.024
Vitamins	0.024
Bone Density Conservation Agents	0.023
Antiemetics	0.023
Glucocorticoids	0.023
GABA Modulators	0.022
Adrenergic beta-1 Receptor Antagonists	0.021
Vitamin B Complex	0.021
Anti-Anxiety Agents	0.021
===== phenotype 5=================================================================
proportion of pts: 0.140023800079
lambda: 20570.2070203
----------------------------------------
Dorsopathies	0.104
Rheumatism, excluding the back	0.089
Hypertensive disease	0.086
Arthropathies and related disorders	0.079
General symptoms	0.055
Disorders of lipoid metabolism	0.053
Range name na	0.051
Symptoms involving skin and other integumentary tissue	0.050
Na	0.045
Symptoms involving respiratory system and other chest symptoms	0.042
Sprains and strains of joints and adjacent muscles	0.041
Organic sleep disorders	0.041
Diseases of esophagus, stomach, and duodenum	0.041
Neurotic, personality, nonpsychotic disorders	0.039
Symptoms involving urinary system	0.037
Other diseases of urinary system	0.035
Acute respiratory infections	0.035
Other symptoms involving abdomen and pelvis	0.028
Symptoms involving digestive system	0.028
Other disorders of female genital tract	0.022
----------------------------------------
Antidepressive Agents, Tricyclic	0.051
Estrogens	0.039
Diuretics	0.039
Analgesics, Non-Narcotic	0.038
Muscle Relaxants, Central	0.037
Tranquilizing Agents	0.036
Anti-Ulcer Agents	0.035
Proton Pump Inhibitors	0.035
Antihypertensive Agents	0.033
Sodium Chloride Symporter Inhibitors	0.032
Glucocorticoids	0.032
Anti-Inflammatory Agents	0.032
Solvents	0.032
Antidepressive Agents, Second-Generation	0.032
Histamine H1 Antagonists	0.032
Anesthetics, Local	0.031
Surface-Active Agents	0.031
Antiemetics	0.031
Serotonin Uptake Inhibitors	0.030
Adrenergic Uptake Inhibitors	0.029
Drug Carriers	0.028
Anti-Allergic Agents	0.028
Histamine H1 Antagonists, Non-Sedating	0.027
Anti-Arrhythmia Agents	0.026
Cyclooxygenase Inhibitors	0.025
Antipyretics	0.024
Dopamine Uptake Inhibitors	0.024
Calcium Channel Blockers	0.024
Hypnotics and Sedatives	0.023
Sodium Potassium Chloride Symporter Inhibitors	0.021
Vasodilator Agents	0.021
Anti-Anxiety Agents	0.021
Bone Density Conservation Agents	0.020
===== phenotype 11=================================================================
proportion of pts: 0.129710432368
lambda: 19968.7709397
----------------------------------------
Range name na	0.075
Hypertensive disease	0.072
Symptoms involving respiratory system and other chest symptoms	0.070
Arthropathies and related disorders	0.065
Rheumatism, excluding the back	0.065
General symptoms	0.056
Acute respiratory infections	0.051
Other disorders of female genital tract	0.047
Other inflammatory conditions of skin and subcutaneous tissue	0.045
Symptoms involving digestive system	0.044
Disorders of the eye and adnexa	0.043
Dorsopathies	0.039
Other diseases of skin and subcutaneous tissue	0.039
Diseases of esophagus, stomach, and duodenum	0.035
Disorders of thyroid gland	0.034
Symptoms involving urinary system	0.032
Other diseases of urinary system	0.031
Nonspecific findings on examination of blood	0.030
Infections of skin and subcutaneous tissue	0.029
Disorders of breast	0.027
Symptoms involving skin and other integumentary tissue	0.025
Diseases of the ear and mastoid process	0.025
Disorders of fluid, electrolyte, and acid-base balance	0.021
----------------------------------------
Hypnotics and Sedatives	0.046
Antirheumatic Agents	0.043
Glucocorticoids	0.042
Anti-Inflammatory Agents	0.042
Immunosuppressive Agents	0.040
GABA Modulators	0.037
Anti-Bacterial Agents	0.037
Dermatologic Agents	0.037
Antimalarials	0.037
Enzyme Inhibitors	0.035
Estrogens	0.035
Protein Synthesis Inhibitors	0.034
Antineoplastic Agents, Hormonal	0.033
Anti-Allergic Agents	0.033
Muscarinic Antagonists	0.033
Anti-Anxiety Agents	0.032
Serotonin Uptake Inhibitors	0.031
Bronchodilator Agents	0.031
Antipruritics	0.031
Histamine H1 Antagonists	0.031
Anticonvulsants	0.030
GABA-A Receptor Agonists	0.030
Antiemetics	0.027
Antifungal Agents	0.026
Antihypertensive Agents	0.025
Antidepressive Agents, Second-Generation	0.025
Anti-Ulcer Agents	0.024
Muscle Relaxants, Central	0.024
Vitamin B Complex	0.024
Hematinics	0.024
Proton Pump Inhibitors	0.022
===== phenotype 44=================================================================
proportion of pts: 0.140023800079
lambda: 19961.9960533
----------------------------------------
Arthropathies and related disorders	0.088
Hypertensive disease	0.085
Diseases of the ear and mastoid process	0.084
Disorders of lipoid metabolism	0.065
Disorders of thyroid gland	0.063
Acute respiratory infections	0.057
Dorsopathies	0.056
Rheumatism, excluding the back	0.055
Nonspecific findings on examination of blood	0.043
Other diseases of intestines and peritoneum	0.040
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.038
Certain traumatic complications and unspecified injuries	0.038
Range name na	0.036
Other symptoms involving abdomen and pelvis	0.035
Other diseases of the upper respiratory tract	0.034
General symptoms	0.034
Diseases of esophagus, stomach, and duodenum	0.032
Symptoms involving head and neck	0.025
Other diseases of skin and subcutaneous tissue	0.025
Sprains and strains of joints and adjacent muscles	0.023
Other disorders of female genital tract	0.022
Symptoms involving urinary system	0.020
----------------------------------------
Bronchodilator Agents	0.064
Anti-Allergic Agents	0.059
Anti-Inflammatory Agents	0.054
Histamine H1 Antagonists, Non-Sedating	0.052
Antihypertensive Agents	0.051
Anti-Inflammatory Agents, Non-Steroidal	0.048
Dermatologic Agents	0.047
Cyclooxygenase Inhibitors	0.045
Antipyretics	0.039
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.036
Anticholesteremic Agents	0.033
Platelet Aggregation Inhibitors	0.033
Parasympatholytics	0.033
Anti-Ulcer Agents	0.033
Lipoxygenase Inhibitors	0.032
Fibrinolytic Agents	0.032
Proton Pump Inhibitors	0.030
Diuretics	0.029
Calcium Channel Blockers	0.029
Glucocorticoids	0.028
Analgesics, Non-Narcotic	0.027
Anti-Asthmatic Agents	0.026
Anti-Bacterial Agents	0.025
Sodium Chloride Symporter Inhibitors	0.024
Vasodilator Agents	0.024
Angiotensin-Converting Enzyme Inhibitors	0.024
Anti-Arrhythmia Agents	0.022
Tocolytic Agents	0.022
===== phenotype 46=================================================================
proportion of pts: 0.131297104324
lambda: 19797.7551533
----------------------------------------
Other forms of heart disease	0.121
Ischemic heart disease	0.113
Other diseases of intestines and peritoneum	0.085
Hypertensive disease	0.079
Range name na	0.076
Symptoms involving respiratory system and other chest symptoms	0.069
Disorders of lipoid metabolism	0.063
Benign neoplasm of other parts of digestive system	0.051
Disorders of the eye and adnexa	0.050
Diseases of arteries, arterioles, and capillaries	0.042
Nephritis, nephrotic syndrome, and nephrosis	0.039
Operations on the musculoskeletal system	0.038
Symptoms involving cardiovascular system	0.037
Diseases of esophagus, stomach, and duodenum	0.036
Miscellaneous diagnostic and therapeutic procedures	0.034
Disorders of fluid, electrolyte, and acid-base balance	0.034
Other diseases of respiratory system	0.033
----------------------------------------
Adjuvants, Anesthesia	0.043
Anesthetics, Intravenous	0.039
Platelet Aggregation Inhibitors	0.037
Fibrinolytic Agents	0.037
Antipyretics	0.036
Cyclooxygenase Inhibitors	0.036
Surface-Active Agents	0.036
Anti-Inflammatory Agents, Non-Steroidal	0.036
Antihypertensive Agents	0.033
Hypnotics and Sedatives	0.033
Explosive Agents	0.031
GABA Modulators	0.031
Vasodilator Agents	0.030
Anti-Arrhythmia Agents	0.029
Adrenergic beta-1 Receptor Antagonists	0.029
Anticholesteremic Agents	0.029
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.029
Sympatholytics	0.028
Purinergic P2Y Receptor Antagonists	0.027
Cardiotonic Agents	0.026
Analgesics, Opioid	0.026
Solvents	0.026
Angiotensin-Converting Enzyme Inhibitors	0.025
Diuretics	0.025
Analgesics, Non-Narcotic	0.024
Narcotics	0.024
Drug Carriers	0.023
Anti-Ulcer Agents	0.023
Hypolipidemic Agents	0.022
Sodium Potassium Chloride Symporter Inhibitors	0.022
Calcium Channel Blockers	0.022
Anti-Anxiety Agents	0.022
Angiotensin II Type 1 Receptor Blockers	0.021
Proton Pump Inhibitors	0.020
Adrenergic alpha-1 Receptor Antagonists	0.020
===== phenotype 9=================================================================
proportion of pts: 0.153510511702
lambda: 19722.2025035
----------------------------------------
Symptoms involving respiratory system and other chest symptoms	0.155
Disorders of lipoid metabolism	0.106
Hypertensive disease	0.103
Acute respiratory infections	0.093
Other forms of heart disease	0.058
Range name na	0.052
Other symptoms involving abdomen and pelvis	0.049
General symptoms	0.049
Chronic obstructive pulmonary disease and allied conditions	0.045
Symptoms involving digestive system	0.040
Diseases of the ear and mastoid process	0.039
Other diseases of urinary system	0.037
Operations on the nose, mouth, and pharynx	0.037
Diseases of esophagus, stomach, and duodenum	0.035
Anemias	0.027
Abnormal results of function studies	0.027
Other diseases of intestines and peritoneum	0.025
Diabetes	0.024
----------------------------------------
Antihypertensive Agents	0.054
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.047
Anticholesteremic Agents	0.045
Cyclooxygenase Inhibitors	0.044
Antipyretics	0.044
Platelet Aggregation Inhibitors	0.043
Anti-Inflammatory Agents, Non-Steroidal	0.043
Fibrinolytic Agents	0.043
Hypolipidemic Agents	0.034
Anti-Ulcer Agents	0.034
Anti-Arrhythmia Agents	0.032
Vasodilator Agents	0.032
Angiotensin-Converting Enzyme Inhibitors	0.031
Proton Pump Inhibitors	0.029
Sympatholytics	0.028
Bronchodilator Agents	0.027
Diuretics	0.027
Hypnotics and Sedatives	0.027
Angiotensin II Type 1 Receptor Blockers	0.026
Adrenergic beta-1 Receptor Antagonists	0.026
Cardiotonic Agents	0.026
Anti-Allergic Agents	0.025
Adrenergic alpha-1 Receptor Antagonists	0.025
GABA Modulators	0.025
Anti-Inflammatory Agents	0.024
Anticoagulants	0.024
Antidepressive Agents, Second-Generation	0.024
Serotonin Uptake Inhibitors	0.023
Analgesics, Non-Narcotic	0.023
Anti-Bacterial Agents	0.023
Rodenticides	0.023
Sodium Chloride Symporter Inhibitors	0.021
===== phenotype 29=================================================================
proportion of pts: 0.124950416501
lambda: 19667.0602049
----------------------------------------
Neurotic, personality, nonpsychotic disorders	0.098
Hereditary and degenerative diseases of the central nervous system	0.058
Symptoms involving respiratory system and other chest symptoms	0.058
Hypertensive disease	0.057
Pain	0.050
Fractures	0.045
Rheumatism, excluding the back	0.043
Dorsopathies	0.043
Symptoms involving head and neck	0.042
Acute respiratory infections	0.040
Other diseases of the upper respiratory tract	0.039
Certain traumatic complications and unspecified injuries	0.036
Range name na	0.034
Other symptoms involving abdomen and pelvis	0.032
Disorders of the eye and adnexa	0.032
General symptoms	0.031
Other diseases of urinary system	0.030
Disorders of the peripheral nervous system	0.029
Na	0.029
Diseases of other endocrine glands	0.028
Symptoms involving nervous and musculoskeletal systems	0.026
Disorders of fluid, electrolyte, and acid-base balance	0.026
Other psychoses	0.025
Other nonspecific abnormal findings	0.023
Drug dependence	0.023
Other bacterial diseases	0.021
----------------------------------------
Anticonvulsants	0.043
Serotonin Uptake Inhibitors	0.041
GABA Modulators	0.038
Anti-Anxiety Agents	0.036
Antihypertensive Agents	0.035
Analgesics, Non-Narcotic	0.034
Antidepressive Agents	0.033
Hypnotics and Sedatives	0.032
Antioxidants	0.031
Analgesics	0.031
Adrenergic Uptake Inhibitors	0.031
Anti-Inflammatory Agents, Non-Steroidal	0.031
Antidepressive Agents, Second-Generation	0.030
Antipyretics	0.030
Antidepressive Agents, Tricyclic	0.030
Calcium Channel Blockers	0.029
Cyclooxygenase Inhibitors	0.029
Anti-Allergic Agents	0.029
Dopamine Uptake Inhibitors	0.028
Anti-Arrhythmia Agents	0.028
Anti-Inflammatory Agents	0.026
Sympatholytics	0.026
Anti-Ulcer Agents	0.026
Excitatory Amino Acid Antagonists	0.025
Vitamins	0.024
Antiemetics	0.024
Proton Pump Inhibitors	0.024
Muscle Relaxants, Central	0.023
Antiparkinson Agents	0.023
Fibrinolytic Agents	0.023
Bone Density Conservation Agents	0.023
Vasodilator Agents	0.022
Dermatologic Agents	0.022
Platelet Aggregation Inhibitors	0.022
Adrenergic beta-1 Receptor Antagonists	0.021
===== phenotype 26=================================================================
proportion of pts: 0.120587068624
lambda: 19433.6055072
----------------------------------------
Other diseases of urinary system	0.090
Hypertensive disease	0.063
Symptoms involving urinary system	0.061
Symptoms involving digestive system	0.060
Rheumatism, excluding the back	0.052
Range name na	0.051
Diabetes	0.047
Other diseases of skin and subcutaneous tissue	0.046
Other forms of heart disease	0.046
Disorders of fluid, electrolyte, and acid-base balance	0.042
Arthropathies and related disorders	0.040
Anemias	0.039
Other symptoms involving abdomen and pelvis	0.038
Nephritis, nephrotic syndrome, and nephrosis	0.038
Disorders of the peripheral nervous system	0.037
Dorsopathies	0.035
Nutritional deficiencies	0.032
Symptoms involving skin and other integumentary tissue	0.031
Other diseases of intestines and peritoneum	0.028
Diseases of veins and lymphatics, and other diseases of circulatory system	0.027
Other inflammatory conditions of skin and subcutaneous tissue	0.026
Mycoses	0.025
Nonspecific findings on examination of blood	0.025
Neoplasm of uncertain behavior of other sites & tissues	0.021
----------------------------------------
Excitatory Amino Acid Antagonists	0.046
Antiparkinson Agents	0.046
Antimanic Agents	0.044
Gastrointestinal Agents	0.040
Analgesics	0.040
Anticonvulsants	0.038
Topoisomerase II Inhibitors	0.037
Calcium Channel Blockers	0.037
Anti-Anxiety Agents	0.035
Angiotensin II Type 1 Receptor Blockers	0.033
Muscarinic Antagonists	0.031
Vasodilator Agents	0.031
Adrenergic alpha-1 Receptor Antagonists	0.031
Antihypertensive Agents	0.030
Sodium Potassium Chloride Symporter Inhibitors	0.030
Histamine H1 Antagonists	0.029
Antipyretics	0.029
Anti-Inflammatory Agents, Non-Steroidal	0.027
Vitamin B Complex	0.027
Platelet Aggregation Inhibitors	0.026
Fibrinolytic Agents	0.026
Cyclooxygenase Inhibitors	0.026
Anti-Arrhythmia Agents	0.026
Anti-Bacterial Agents	0.026
Analgesics, Non-Narcotic	0.025
Hypoglycemic Agents	0.025
Vitamins	0.024
Diuretics	0.024
Antioxidants	0.023
Antiemetics	0.023
Bone Density Conservation Agents	0.022
Sympatholytics	0.021
Adrenergic beta-1 Receptor Antagonists	0.020
===== phenotype 25=================================================================
proportion of pts: 0.131297104324
lambda: 19156.8752091
----------------------------------------
Other diseases of the upper respiratory tract	0.109
Hypertensive disease	0.096
Symptoms involving respiratory system and other chest symptoms	0.091
Chronic obstructive pulmonary disease and allied conditions	0.080
Acute respiratory infections	0.064
Arthropathies and related disorders	0.058
Rheumatism, excluding the back	0.056
Disorders of lipoid metabolism	0.054
Diseases of esophagus, stomach, and duodenum	0.051
Range name na	0.047
Dorsopathies	0.045
Symptoms involving head and neck	0.042
Disorders of the eye and adnexa	0.037
General symptoms	0.036
Symptoms involving skin and other integumentary tissue	0.034
Organic sleep disorders	0.033
Disorders of the peripheral nervous system	0.023
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.022
Other diseases of respiratory system	0.021
----------------------------------------
Bronchodilator Agents	0.069
Anti-Asthmatic Agents	0.059
Anti-Allergic Agents	0.057
Histamine H1 Antagonists, Non-Sedating	0.057
Anti-Inflammatory Agents	0.052
Dermatologic Agents	0.046
Leukotriene Antagonists	0.045
Sympathomimetics	0.045
Glucocorticoids	0.043
Lipoxygenase Inhibitors	0.041
Adrenergic beta-2 Receptor Agonists	0.039
Tocolytic Agents	0.037
Antineoplastic Agents, Hormonal	0.036
Antihypertensive Agents	0.035
Calcium Channel Blockers	0.032
Anti-Ulcer Agents	0.031
Anti-Bacterial Agents	0.031
Vasodilator Agents	0.030
Proton Pump Inhibitors	0.030
Vasoconstrictor Agents	0.028
Mydriatics	0.027
Adrenergic alpha-Agonists	0.023
Enzyme Inhibitors	0.022
Vitamins	0.022
Anti-Inflammatory Agents, Non-Steroidal	0.021
Muscle Relaxants, Central	0.021
Bone Density Conservation Agents	0.021
===== phenotype 7=================================================================
proportion of pts: 0.135263784213
lambda: 19112.1870406
----------------------------------------
Disorders of the peripheral nervous system	0.110
Diabetes	0.106
Rheumatism, excluding the back	0.099
Arthropathies and related disorders	0.097
Hypertensive disease	0.090
Disorders of lipoid metabolism	0.087
Dorsopathies	0.055
Disorders of the eye and adnexa	0.048
General symptoms	0.047
Range name na	0.041
Organic sleep disorders	0.039
Symptoms involving respiratory system and other chest symptoms	0.036
Sprains and strains of joints and adjacent muscles	0.034
Symptoms involving skin and other integumentary tissue	0.033
Acute respiratory infections	0.030
Na	0.025
Mycoses	0.023
----------------------------------------
Analgesics	0.057
Excitatory Amino Acid Antagonists	0.053
Anticonvulsants	0.052
Antiparkinson Agents	0.051
Antimanic Agents	0.050
Calcium Channel Blockers	0.049
Hypoglycemic Agents	0.048
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.045
Anti-Inflammatory Agents, Non-Steroidal	0.044
Anti-Anxiety Agents	0.043
Antihypertensive Agents	0.042
Cyclooxygenase Inhibitors	0.042
Platelet Aggregation Inhibitors	0.040
Antipyretics	0.040
Anticholesteremic Agents	0.039
Fibrinolytic Agents	0.038
Serotonin Uptake Inhibitors	0.034
Angiotensin-Converting Enzyme Inhibitors	0.031
Hypolipidemic Agents	0.029
Adrenergic Uptake Inhibitors	0.029
Antidepressive Agents	0.028
Vasodilator Agents	0.025
Dopamine Uptake Inhibitors	0.025
Cardiotonic Agents	0.024
Analgesics, Non-Narcotic	0.021
Anti-Ulcer Agents	0.020
===== phenotype 4=================================================================
proportion of pts: 0.122570408568
lambda: 19052.2108725
----------------------------------------
Ischemic heart disease	0.098
Disorders of lipoid metabolism	0.089
Hypertensive disease	0.076
Dorsopathies	0.066
Cerebrovascular disease	0.054
Symptoms involving head and neck	0.051
Range name na	0.050
Other forms of heart disease	0.050
Symptoms involving respiratory system and other chest symptoms	0.044
Acute respiratory infections	0.039
Chronic obstructive pulmonary disease and allied conditions	0.039
Pneumonia and influenza	0.037
Disorders of the eye and adnexa	0.037
Diabetes	0.037
Disorders of the peripheral nervous system	0.034
Arthropathies and related disorders	0.034
Other diseases of the upper respiratory tract	0.033
Anemias	0.029
Diseases of the ear and mastoid process	0.027
Symptoms involving skin and other integumentary tissue	0.026
General symptoms	0.025
Other diseases of respiratory system	0.023
----------------------------------------
Anticonvulsants	0.063
Excitatory Amino Acid Antagonists	0.057
Analgesics	0.054
Antiparkinson Agents	0.053
Anti-Anxiety Agents	0.049
Antimanic Agents	0.049
Explosive Agents	0.039
Purinergic P2Y Receptor Antagonists	0.036
Angiotensin II Type 1 Receptor Blockers	0.036
Calcium Channel Blockers	0.034
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.033
Platelet Aggregation Inhibitors	0.031
Anticholesteremic Agents	0.031
Diuretics	0.030
Sodium Potassium Chloride Symporter Inhibitors	0.028
Anti-Ulcer Agents	0.028
Proton Pump Inhibitors	0.028
Sodium Chloride Symporter Inhibitors	0.027
Hypnotics and Sedatives	0.026
Fibrinolytic Agents	0.026
Anti-Arrhythmia Agents	0.026
Antihypertensive Agents	0.026
Cyclooxygenase Inhibitors	0.025
Antipyretics	0.025
Sympatholytics	0.025
Anti-Inflammatory Agents, Non-Steroidal	0.024
Analgesics, Non-Narcotic	0.023
Vasodilator Agents	0.023
Hypolipidemic Agents	0.023
Adrenergic beta-1 Receptor Antagonists	0.021
===== phenotype 0=================================================================
proportion of pts: 0.144783815946
lambda: 18881.0692832
----------------------------------------
Hypertensive disease	0.105
Disorders of lipoid metabolism	0.099
Other diseases of urinary system	0.080
Diseases of esophagus, stomach, and duodenum	0.074
Symptoms involving urinary system	0.066
Ischemic heart disease	0.062
Range name na	0.059
Disorders of the eye and adnexa	0.057
Acute respiratory infections	0.044
Other diseases of skin and subcutaneous tissue	0.035
Symptoms involving respiratory system and other chest symptoms	0.035
Other diseases of the upper respiratory tract	0.035
Diseases of male genital organs	0.033
Disorders of thyroid gland	0.031
Diseases of other endocrine glands	0.026
Other symptoms involving abdomen and pelvis	0.026
Other diseases of intestines and peritoneum	0.024
Malignant neoplasm of badder, kidney and other urinary organs	0.024
Symptoms involving digestive system	0.023
Inflammatory disease of female pelvic organs	0.022
Nonspecific findings on examination of blood	0.021
Other inflammatory conditions of skin and subcutaneous tissue	0.021
----------------------------------------
Anti-Inflammatory Agents, Non-Steroidal	0.057
Cyclooxygenase Inhibitors	0.055
Antihypertensive Agents	0.055
Antipyretics	0.053
Platelet Aggregation Inhibitors	0.051
Fibrinolytic Agents	0.050
Anti-Ulcer Agents	0.050
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.047
Proton Pump Inhibitors	0.045
Anticholesteremic Agents	0.043
Anti-Allergic Agents	0.039
Vasodilator Agents	0.033
Hypolipidemic Agents	0.032
Anti-Inflammatory Agents	0.032
Anti-Bacterial Agents	0.032
Angiotensin II Type 1 Receptor Blockers	0.031
Histamine H1 Antagonists, Non-Sedating	0.031
Topoisomerase II Inhibitors	0.030
Anti-Infective Agents	0.026
Sodium Chloride Symporter Inhibitors	0.025
Vitamin B Complex	0.024
Bronchodilator Agents	0.024
Anti-Infective Agents, Urinary	0.024
Antiemetics	0.024
Vitamins	0.024
Diuretics	0.023
Anti-Arrhythmia Agents	0.021
Angiotensin-Converting Enzyme Inhibitors	0.020
===== phenotype 47=================================================================
proportion of pts: 0.122967076557
lambda: 18637.1222382
----------------------------------------
Symptoms involving digestive system	0.081
Symptoms involving skin and other integumentary tissue	0.062
Hypertensive disease	0.061
Symptoms involving respiratory system and other chest symptoms	0.061
Rheumatism, excluding the back	0.061
Nephritis, nephrotic syndrome, and nephrosis	0.060
General symptoms	0.059
Disorders of fluid, electrolyte, and acid-base balance	0.058
Other symptoms involving abdomen and pelvis	0.058
Disorders of lipoid metabolism	0.057
Other forms of heart disease	0.057
Diseases of esophagus, stomach, and duodenum	0.053
Ischemic heart disease	0.050
Other diseases of urinary system	0.048
Dorsopathies	0.040
Diseases of veins and lymphatics, and other diseases of circulatory system	0.035
Other diseases of intestines and peritoneum	0.031
Other disorders of female genital tract	0.024
Noninfectious enteritis and colitis	0.023
Overweight, obesity and other hyperalimentation	0.021
----------------------------------------
Diuretics	0.041
Anti-Ulcer Agents	0.040
Vasodilator Agents	0.040
Sympatholytics	0.039
Adrenergic alpha-2 Receptor Agonists	0.039
Mineralocorticoid Receptor Antagonists	0.038
Parasympatholytics	0.037
Proton Pump Inhibitors	0.037
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.036
Antihypertensive Agents	0.035
Anticholesteremic Agents	0.035
Anti-Arrhythmia Agents	0.035
Adrenergic beta-Antagonists	0.032
Adrenergic beta-1 Receptor Antagonists	0.032
Gout Suppressants	0.032
Antacids	0.031
Anti-Inflammatory Agents, Non-Steroidal	0.031
Platelet Aggregation Inhibitors	0.031
Calcium Channel Blockers	0.031
Antipyretics	0.030
Vitamins	0.030
Fibrinolytic Agents	0.030
Sodium Chloride Symporter Inhibitors	0.028
Cyclooxygenase Inhibitors	0.028
Explosive Agents	0.028
Angiotensin II Type 1 Receptor Blockers	0.026
Hypolipidemic Agents	0.026
Analgesics	0.026
Bone Density Conservation Agents	0.025
Sodium Potassium Chloride Symporter Inhibitors	0.025
Antipruritics	0.024
===== phenotype 10=================================================================
proportion of pts: 0.124950416501
lambda: 18376.7884312
----------------------------------------
Disorders of thyroid gland	0.134
Hypertensive disease	0.085
Disorders of lipoid metabolism	0.078
Rheumatism, excluding the back	0.070
Diabetes	0.065
Arthropathies and related disorders	0.065
Range name na	0.060
Disorders of the eye and adnexa	0.053
General symptoms	0.053
Symptoms involving respiratory system and other chest symptoms	0.047
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.043
Other symptoms involving abdomen and pelvis	0.039
Diseases of esophagus, stomach, and duodenum	0.035
Other diseases of intestines and peritoneum	0.034
Other diseases of skin and subcutaneous tissue	0.033
Symptoms involving digestive system	0.032
Diseases of veins and lymphatics, and other diseases of circulatory system	0.027
Mycoses	0.026
Other disorders of the central nervous system	0.024
----------------------------------------
Anticonvulsants	0.046
Anti-Anxiety Agents	0.044
Antiemetics	0.044
Adjuvants, Anesthesia	0.040
Histamine H1 Antagonists	0.039
Anesthetics, Local	0.037
GABA Modulators	0.035
Voltage-Gated Sodium Channel Blockers	0.033
Antipruritics	0.033
Hypnotics and Sedatives	0.032
Surface-Active Agents	0.031
Analgesics	0.030
Antidepressive Agents, Tricyclic	0.029
Proton Pump Inhibitors	0.028
Anticholesteremic Agents	0.028
Solvents	0.028
Analgesics, Opioid	0.028
Antifungal Agents	0.027
Anti-Ulcer Agents	0.027
Narcotics	0.027
Sodium Potassium Chloride Symporter Inhibitors	0.026
Excitatory Amino Acid Antagonists	0.026
Calcium Channel Blockers	0.026
Diuretics	0.026
Antimanic Agents	0.025
Hypolipidemic Agents	0.024
Anti-Arrhythmia Agents	0.024
Analgesics, Non-Narcotic	0.024
Antiparkinson Agents	0.024
Drug Carriers	0.023
Muscle Relaxants, Central	0.022
Anti-Allergic Agents	0.022
Hypoglycemic Agents	0.021
Antipsychotic Agents	0.021
===== phenotype 36=================================================================
proportion of pts: 0.145973819913
lambda: 18344.4596065
----------------------------------------
Diabetes	0.193
Disorders of the eye and adnexa	0.128
Hypertensive disease	0.117
Disorders of lipoid metabolism	0.115
Range name na	0.080
Nonspecific findings on examination of urine	0.051
Nephritis, nephrotic syndrome, and nephrosis	0.051
Dorsopathies	0.037
Mycoses	0.029
Arthropathies and related disorders	0.028
Abnormal results of function studies	0.028
Nonspecific findings on examination of blood	0.026
Other diseases of skin and subcutaneous tissue	0.025
Disorders of the peripheral nervous system	0.024
Infections of skin and subcutaneous tissue	0.023
Symptoms involving respiratory system and other chest symptoms	0.022
Overweight, obesity and other hyperalimentation	0.022
----------------------------------------
Hypoglycemic Agents	0.065
Antihypertensive Agents	0.056
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.053
Anticholesteremic Agents	0.049
Antipyretics	0.045
Cyclooxygenase Inhibitors	0.043
Anti-Inflammatory Agents, Non-Steroidal	0.043
Platelet Aggregation Inhibitors	0.042
Fibrinolytic Agents	0.040
Diuretics	0.039
Anti-Arrhythmia Agents	0.038
Calcium Channel Blockers	0.036
Vasodilator Agents	0.035
Sodium Chloride Symporter Inhibitors	0.035
Angiotensin-Converting Enzyme Inhibitors	0.034
Hypolipidemic Agents	0.032
Sympatholytics	0.029
Adrenergic beta-1 Receptor Antagonists	0.028
Anti-Inflammatory Agents	0.026
Tocolytic Agents	0.025
Anti-Bacterial Agents	0.025
Cardiotonic Agents	0.025
Glucocorticoids	0.024
Immunosuppressive Agents	0.024
Anti-Ulcer Agents	0.024
Proton Pump Inhibitors	0.023
Vitamins	0.023
Bone Density Conservation Agents	0.021
Analgesics, Non-Narcotic	0.020
===== phenotype 38=================================================================
proportion of pts: 0.107893692979
lambda: 18027.4163888
----------------------------------------
Dorsopathies	0.077
Rheumatism, excluding the back	0.069
Hypertensive disease	0.064
Arthropathies and related disorders	0.063
Na	0.057
Range name na	0.052
Other inflammatory conditions of skin and subcutaneous tissue	0.045
Neurotic, personality, nonpsychotic disorders	0.044
Disorders of lipoid metabolism	0.038
Organic sleep disorders	0.038
Infections of skin and subcutaneous tissue	0.037
Symptoms involving cardiovascular system	0.035
Symptoms involving skin and other integumentary tissue	0.035
General symptoms	0.034
Disorders of the peripheral nervous system	0.032
Pain	0.030
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.029
Overweight, obesity and other hyperalimentation	0.029
Mycoses	0.028
Other symptoms involving abdomen and pelvis	0.027
Other diseases of respiratory system	0.025
Sprains and strains of joints and adjacent muscles	0.025
Symptoms concerning nutrition, metabolism, and development	0.024
Other psychoses	0.023
Neoplasm of uncertain behavior of other sites & tissues	0.020
Drug dependence	0.020
----------------------------------------
Voltage-Gated Sodium Channel Blockers	0.042
Immunosuppressive Agents	0.041
Antirheumatic Agents	0.040
Analgesics, Opioid	0.038
Narcotics	0.037
Enzyme Inhibitors	0.037
Excitatory Amino Acid Antagonists	0.036
Antimanic Agents	0.036
Sympatholytics	0.033
Anticonvulsants	0.033
Antifungal Agents	0.033
Anesthetics, Local	0.033
Antiparkinson Agents	0.032
Serotonin Uptake Inhibitors	0.031
Anti-Arrhythmia Agents	0.030
GABA-A Receptor Agonists	0.030
Adrenergic beta-1 Receptor Antagonists	0.029
Antimetabolites, Antineoplastic	0.029
Antipsychotic Agents	0.029
GABA Modulators	0.028
Analgesics	0.028
Dermatologic Agents	0.028
Hypnotics and Sedatives	0.028
Antidepressive Agents, Second-Generation	0.027
Folic Acid Antagonists	0.027
Anti-Anxiety Agents	0.026
Antidepressive Agents	0.026
Antihypertensive Agents	0.023
Antiemetics	0.023
Calcium Channel Blockers	0.022
Nucleic Acid Synthesis Inhibitors	0.021
Abortifacient Agents, Nonsteroidal	0.021
Muscle Relaxants, Central	0.021
===== phenotype 39=================================================================
proportion of pts: 0.10392701309
lambda: 17640.3084021
----------------------------------------
Pneumonia and influenza	0.101
Symptoms involving respiratory system and other chest symptoms	0.088
Other diseases of respiratory system	0.087
Chronic obstructive pulmonary disease and allied conditions	0.074
Other forms of heart disease	0.066
Nephritis, nephrotic syndrome, and nephrosis	0.065
Ischemic heart disease	0.053
Disorders of fluid, electrolyte, and acid-base balance	0.050
Anemias	0.050
General symptoms	0.049
Ill-defined and unknown causes of morbidity and mortality	0.049
Hypertensive disease	0.049
Other diseases of urinary system	0.040
Disorders of lipoid metabolism	0.030
Range name na	0.030
Other diseases of the blood	0.028
Diseases of pulmonary circulation	0.024
Operations on the nose, mouth, and pharynx	0.024
Other bacterial diseases	0.022
Disorders of thyroid gland	0.021
----------------------------------------
Topoisomerase II Inhibitors	0.047
Tocolytic Agents	0.044
Bronchodilator Agents	0.041
Adrenergic beta-2 Receptor Agonists	0.039
Anti-Bacterial Agents	0.038
Cholinergic Antagonists	0.036
Glucocorticoids	0.033
Antipyretics	0.031
Anti-Inflammatory Agents	0.031
Vasodilator Agents	0.031
Sodium Potassium Chloride Symporter Inhibitors	0.031
Anti-Infective Agents, Urinary	0.030
Anti-Allergic Agents	0.030
Antihypertensive Agents	0.030
Diuretics	0.030
Analgesics, Non-Narcotic	0.030
Antineoplastic Agents, Hormonal	0.030
Histamine H1 Antagonists, Non-Sedating	0.028
Cyclooxygenase Inhibitors	0.027
Fibrinolytic Agents	0.027
Calcium Channel Blockers	0.027
Anti-Ulcer Agents	0.026
Anti-Inflammatory Agents, Non-Steroidal	0.026
Antipruritics	0.026
Enzyme Inhibitors	0.026
Platelet Aggregation Inhibitors	0.025
Serotonin Uptake Inhibitors	0.025
Anti-Arrhythmia Agents	0.025
Sympatholytics	0.024
Proton Pump Inhibitors	0.023
Adrenergic beta-1 Receptor Antagonists	0.021
Anticholesteremic Agents	0.021
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.021
Antiemetics	0.020
===== phenotype 23=================================================================
proportion of pts: 0.0789369297898
lambda: 17513.5437393
----------------------------------------
Miscellaneous diagnostic and therapeutic procedures	0.112
Operations on the cardiovascular system	0.110
Other diseases of respiratory system	0.077
Symptoms involving respiratory system and other chest symptoms	0.064
Ischemic heart disease	0.058
Other forms of heart disease	0.053
Range name na	0.042
Anemias	0.041
Diseases of veins and lymphatics, and other diseases of circulatory system	0.039
Diseases of arteries, arterioles, and capillaries	0.038
Hypertensive disease	0.038
